Purpose: Evidence on the efficacy of desmopressin in nocturia in patients with neurological diseases is still very limited except for multiple sclerosis (MS). Our aim was to evaluate the efficacy and safety of desmopressin treatment on nocturia in patients with underlying neurological diseases.
Methods: Studies were identified by electronic search of PubMed, Embase, Cochrane, CINAHL, and Google Scholar databases.